Coyle Financial Counsel LLC Zoetis Inc. Transaction History

Coyle Financial Counsel LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$83.5 - $93.23 $148,964 - $166,322	-1,784 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$79.9 - $89.2 $142,541 - $159,132	1,784 New	1,784 $152,000
Q1 2018 May 03, 2018	SELL	$71.51 - $84.69 $1.18 Million - $1.4 Million	-16,532 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$63.24 - $72.8 $13,849 - $15,943	-219 Reduced 1.31%	16,532 $1.19 Million
Q2 2017 Aug 14, 2017	BUY	N/A	16,751	16,751 $1.05 Million

1,923

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Coyle Financial Counsel LLC, based on Form 13F filings with the SEC.

Stay updated on Coyle Financial Counsel LLC with notifications on news.